We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

137 hedge funds and large institutions have $354M invested in Aerie Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 53 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,011% more call options, than puts

Call options by funds: $100K | Put options by funds: $9K

33% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 15

1% more funds holding

Funds holding: 136 → 137 (+1)

19% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 53

19% less capital invested

Capital invested by funds: $437M → $354M (-$83.3M)

Holders
137
Holders Change
+1
Holders Change %
+0.74%
% of All Funds
2.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
43
Reduced
53
Closed
15
Calls
$100K
Puts
$9K
Net Calls
+$91K
Net Calls Change
+$131K

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$8.68M
2
Deutsche Bank
Deutsche Bank
Germany
+$5.07M
3
FAM
Fred Alger Management
New York
+$3.87M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.8M
5
Walleye Capital
Walleye Capital
New York
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$8.15M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.75M
3
GIM
Granahan Investment Management
Massachusetts
-$6.21M
4
Millennium Management
Millennium Management
New York
-$4.15M
5
PHS
PFM Health Sciences
California
-$2.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$4.22M -$189K -26,850 -5%
GIP
27
Granite Investment Partners
California
$3.51M -$493K -70,000 -13%
Northern Trust
28
Northern Trust
Illinois
$3.39M +$70.5K +10,001 +2%
N
29
Nuveen
North Carolina
$3.37M +$458K +64,974 +17%
Marshall Wace
30
Marshall Wace
United Kingdom
$3.26M +$2.16M +305,951 +238%
Charles Schwab
31
Charles Schwab
California
$2.61M +$51.5K +7,302 +2%
NAM
32
Nexpoint Asset Management
Texas
$2.32M – – –
DCM
33
DAFNA Capital Management
California
$2.17M – – –
Wellington Management Group
34
Wellington Management Group
Massachusetts
$2.01M – – –
SCM
35
Stonepine Capital Management
Oregon
$1.88M +$1.11M +157,335 +168%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$1.86M +$1.32M +187,899 +311%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.71M +$46.9K +6,648 +3%
JAMONY
38
Jacob Asset Management of New York
California
$1.58M -$257K -36,420 -15%
Stifel Financial
39
Stifel Financial
Missouri
$1.42M +$35.3K +5,012 +3%
Allianz Asset Management
40
Allianz Asset Management
Germany
$1.27M +$107K +15,170 +10%
EWM
41
Endurance Wealth Management
Rhode Island
$1.26M -$35.2K -5,000 -3%
DA
42
DCF Advisers
Connecticut
$1.25M -$158K -22,400 -12%
PP
43
PDT Partners
New York
$1.18M -$27.3K -3,878 -2%
Goldman Sachs
44
Goldman Sachs
New York
$1.14M -$858K -121,767 -45%
Voloridge Investment Management
45
Voloridge Investment Management
Florida
$928K -$781K -110,859 -47%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$832K +$73.3K +10,399 +10%
Swiss National Bank
47
Swiss National Bank
Switzerland
$770K -$26.1K -3,700 -3%
Alyeska Investment Group
48
Alyeska Investment Group
Illinois
$750K – – –
Citadel Advisors
49
Citadel Advisors
Florida
$690K -$5.46K -775 -0.8%
Nordea Investment Management
50
Nordea Investment Management
Sweden
$690K +$360K +51,070 +133%
1
2
3 4 5

AERI Hedge Fund Activity: Q2 2022 in Review

137 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q2 2022, worth a combined $354M — down 19% from $437M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new AERI positions and 15 closed out — a net gain of 5 holders — while 43 added to existing stakes and 53 trimmed.

The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $8.68M. The largest seller was Morgan Stanley, cutting an estimated $8.15M.

  • 137 institutional investors held Aerie Pharmaceuticals (AERI) as of Q2 2022, up from 136 in Q1 2022.
  • Funds reported $354M of Aerie Pharmaceuticals stock for Q2 2022, down 19% quarter-over-quarter.
  • 20 funds opened new Aerie Pharmaceuticals positions in Q2 2022 and 15 closed out, a net change of +5 holders.
  • The largest Aerie Pharmaceuticals buyer in Q2 2022 was Rubric Capital Management (New York), an estimated $8.68M added.
  • The largest Aerie Pharmaceuticals seller in Q2 2022 was Morgan Stanley, an estimated $8.15M sold.

Based on aggregated 13F filings for Q2 2022.